Viewing Study NCT01751568


Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2026-02-20 @ 10:12 PM
Study NCT ID: NCT01751568
Status: COMPLETED
Last Update Posted: 2021-11-05
First Post: 2012-12-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
None Tuberculosis View
Keywords: